PASITHEA THERAPEUTICS CORP. Other Nonoperating Income
PASITHEA THERAPEUTICS CORP. (KTTA) reported Other Nonoperating Income of $38.18 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncome · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. other nonoperating income for the quarter ending 2026-06-30 was $38.18K, a 96.17% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. other nonoperating income for the quarter ending 2026-03-31 was $24.18K.
- PASITHEA THERAPEUTICS CORP. other nonoperating income for the quarter ending 2025-12-31 was $352.45K.
- PASITHEA THERAPEUTICS CORP. other nonoperating income for the quarter ending 2025-09-30 was $8.62K.
- PASITHEA THERAPEUTICS CORP. other nonoperating income for fiscal 2025 was $380.53K.
| Period end | Other Nonoperating Income 3 month | Other Nonoperating Income 6 month | Other Nonoperating Income 9 month | Other Nonoperating Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $38.18K 10-Q · filed 2026-08-14 | $62.37K 10-Q · filed 2026-08-14 | $414.81K derived: sum of 3 quarters · filed 2026-08-14 | $423.43K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $24.18K 10-Q · filed 2026-05-15 | $376.63K derived: sum of 2 quarters · filed 2026-05-15 | $385.25K derived: sum of 3 quarters · filed 2026-05-15 | $404.71K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $352.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $361.07K derived: sum of 2 quarters · filed 2026-03-30 | $380.53K derived: sum of 3 quarters · filed 2026-08-14 | $380.53K 10-K · filed 2026-03-30 |
| 2025-09-30 | $8.62K 10-Q · filed 2025-11-13 | $28.08K derived: sum of 2 quarters · filed 2026-08-14 | $28.08K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $19.46K 10-Q · filed 2026-08-14 | $19.46K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |